<?xml version="1.0" encoding="UTF-8"?>
<p>HCV elimination is possible with DAA therapies. However, beyond issues of screening, there are issues that limit diagnosis, referral, and treatment for all infected patients. From a health‐services perspective, the World Health Organization has set five service coverage targets for elimination of viral hepatitis as a public health threat by 2030, including targeting vertical transmission prevention, blood and injection safety, PWID harm reduction, and antiviral treatment provision.
 <xref rid="hep41480-bib-0026" ref-type="ref">26</xref> However, a recent Markov modeling analysis found that 36 of 45 (80%) high‐income countries/territories would be projected to not meet these elimination targets by this time, including the United States.
 <xref rid="hep41480-bib-0027" ref-type="ref">27</xref> Further aggressive policy measures will be needed if this benchmark were to be met.
</p>
